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Infrared microspectroscopytive disorder that involves the misfolding, aggregation and accumulation of the
prion protein (PrP). The normal cellular PrP (PrPC) is rich in α-helical secondary structure, whereas the
disease-associated pathogenic form of the protein (PrPSc) has an anomalously high β-sheet content. In this
study, protein structural changes were examined in situ in the dorsal root ganglia from perorally 263K
scrapie-infected and mock-infected hamsters using synchrotron Fourier Transform InfraRed Microspectro-
scopy (FTIRM) at four time points over the course of the disease (pre-clinical, 100 and 130 days post-infection
(dpi); ﬁrst clinical signs (∼145 dpi); and terminal (∼170 dpi)). Results showed clear changes in the total
protein content, structure, and distribution as the disease progressed. At pre-clinical time points, the scrapie-
infected animals exhibited a signiﬁcant increase in protein expression, but the β-sheet protein content was
signiﬁcantly lower than controls. Based on these ﬁndings, we suggest that the pre-clinical stages of scrapie
are characterized by an overexpression of proteins low in β-sheet content. As the disease progressed, the β-
sheet content increased signiﬁcantly. Immunostaining with a PrP-speciﬁc antibody, 3F4, conﬁrmed that this
increase was partly – but not solely – due to the formation of PrPSc in the tissue and indicated that other
proteins high in β-sheet were produced, either by overexpression or misfolding. Elevated β-sheet was
observed near the cell membrane at pre-clinical time points and also in the cytoplasm of infected neurons at
later stages of infection. At the terminal stage of the disease, the protein expression declined signiﬁcantly,
likely due to degeneration and death of neurons. These dramatic changes in protein content and structure,
especially at pre-clinical time points, emphasize the possibility for identifying other proteins involved in
early pathogenesis, which are important for a further understanding of the disease.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionA characteristic feature of scrapie, a neurodegenerative disorder
naturally occurring in sheep and goats, is the accumulation of a β-
sheet rich protein termed PrPSc, or scrapie-associated prion protein,
predominantly in the brain and spinal cord. First described in 1732 in
sheep, scrapie belongs to the family of Transmissible Spongiform
Encephalopathies (TSEs), which can also occur in cattle (bovine
spongiform encephalopathy), deer (chronic wasting disease), mink
(transmissible mink encephalopathy) and other animals. The Creutz-
feldt–Jakob disease in humans can occur sporadically but may also
have genetic and infectious origins, which is a unique feature of this
group of diseases. According to the prion hypothesis, the causative
agent of TSEs is believed to be a proteinaceous infectious particlephalopathy; DRG, dorsal root
n; FTIRM, Fourier Transform
1 631 344 3238.
l rights reserved.(“prion”) that lacks agent-speciﬁc nucleic acid and consists mainly – if
not entirely – of misfolded and pathologically aggregated prion
protein [1]. Normal PrP and its pathological isoform have an identical
amino acid sequence but different secondary (and tertiary) structures.
PrPC, the cellular prion protein, mainly expressed by neuronal cells, is
high in α-helix (42%) and consists of only 3% β-sheet, whereas the
misfolded or disease-associated form PrPSc shows a high amount of β-
sheet structure (43%) and has less α-helix (30%) [2].
The nervous system of hamsters orally infected with scrapie has
been studied extensively for the temporal–spatial course of PrPSc
deposition (for review see: [3]). After centripetally reaching the spinal
cord, subsequent centrifugal spread of PrPSc depositionproceeds to the
corresponding afferent dorsal root ganglia (DRG, nodules on a dorsal
spinal root that contain cell bodies of afferent nerve ﬁbers), where the
protein can ﬁrst be detected 76 days post-infection in half of the
examined hamsters [4–6]. Immunostained sections have shown that
PrPSc does not accumulate in all neurons of theDRG,where only certain
cells stain strongly. In prion research, conventional techniques like
Western Blot analysis are sensitive for examining the total amount of
PrPSc in homogenized tissue. In situ, PET blotting (parafﬁn embedded
Fig. 1. Mean values±average deviation for the relative (A) β-sheet protein content, (B)
α-helix protein content, and (C) total protein content for scrapie-infected (black lines)
and control (gray lines) hamster dorsal root ganglia at the four investigated time points.
Asterisks mark signiﬁcant differences (pb0.05) between scrapie and control.
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tissue, providing spatially-resolved information on the location of
PrPSc. However, both techniques are limited to the detection of PrPSc,
and do not provide information on other compositional changes that
occur throughout the disease, especially at early time points in
pathogenesis before PrPSc shows detectable accumulation.
In contrast, Fourier Transform InfraredMicrospectroscopy (FTIRM) is
an in situ technique that is not restricted to the detection of PrPSc. In fact,
an infrared spectrum of a biological sample is composed of character-
istic absorption bands that originate from all tissue components, e.g.
proteins, lipids, nucleic acids, and carbohydrates. Since the combination
of all molecular parameters (structure, composition, and/or interac-
tions) in a speciﬁc tissue, cell type, or subcellular component is unique,
FTIRM is an in situ technique for examining the molecular composition
of biological materials [8]. No labels, stains or dyes are required for FTIR
microspectroscopy and it is a non-destructive, sensitive and fast
analytical tool. Thus, coupled with PrPSc-speciﬁc imaging techniques,
FTIRM can be used to determine compositional changes in prion-
infected tissue associated with scrapie pathogenesis [9,10].
In this study, protein content, structure, and distribution through-
out scrapie pathogenesis were investigated using synchrotron FTIRM.
Syrian hamsters (Mesocricetus auratus) perorally infected with scrapie
strain 263K were studied at 4 different time points: 100 days post-
infection (dpi), 130 dpi, at ﬁrst clinical signs (fcs, ∼145 dpi) and at the
terminal stage (∼170 dpi) of the disease. The total protein, the α-
helical protein, and the β-sheet protein contents and distributions
were determined as a function of disease progression and correlated
with PrPSc immunostaining. The aim of this study was to examine
changes in protein composition throughout scrapie pathogenesis, and
to correlate these ﬁndings with the temporal–spatial course of PrPSc
deposition. Identiﬁcation of protein changes involved in early scrapie
pathogenesis is important for understanding the disease process and
for identifying new approaches for early disease detection and
treatment with other, target-oriented techniques.
2. Materials and methods
2.1. Animal experiments and tissue preparation
All animal experiments were carried out in accordance with
European, German, and USA legal and ethical regulations. 20 outbred
Syrian hamsters at an age of approximately 8 weeks were fed food
pellets containing 100 μl of a 10% (w/v) hamster brain homogenate
(corresponding to 10 mg of tissue) from terminally ill 263K scrapie–
infected donors or uninfected controls as described elsewhere [11].
Twelve mock-infected hamsters of the same age were similarly fed
with normal brain homogenate and served as controls. Five infected
and three control hamsters each were euthanized with CO2, at each of
four time points: 100 dpi, 130 dpi, fcs (∼145 dpi), and at the terminal
stage of the disease (∼170 dpi). While the ﬁrst two time points were
ﬁxed dates, the fcs and terminal stages depend on the progression of
the disease in each individual animal. Fcs is deﬁned as a stage where
the animals start to show symptoms that are speciﬁc for a 263K scrapie
infection in hamsters. These are most commonly a hypersensitivity to
touch and noise, where the animals often twitch, or have difﬁculties in
maintaining balance and rising from a supine position. At the terminal
stage, animals showheadbobbing, ataxia of gait, and generalized tremor.
After euthanizing the animals, the dorsal root ganglia attached to
the thoracic spinal cord were removed and stored at −70 °C. After
embedding the samples in Jung tissue freezing medium (Leica
Instruments, Germany), 10 μm thick cryosections were cut at a
temperature of −20 °C and mounted on IR transparent slides (CaF2,
1 mm in thickness) (Korth Kristalle GmbH, Altenholz, Germany).
Adjacent sections were cut at the same thickness and mounted on
standard glass microscope slides for immunostaining. The CaF2 slides
were kept in a dry and dark environment until the FTIR microspectro-scopic measurements were carried out. One animal died before
reaching the stage of fcs, resulting in a total of 19 infected and 12
mock-infected control animals included in the study.
2.2. Immunohistochemistry
Adjacent sections on glass slides were stained for PrP using the
monoclonal antibody 3F4 as described previously [12]. In short, the
slideswereﬁxed three times: 5min each in 50,100 and50% ethanol, and
then rehydrated in distilled water. The ganglia were then treated with
10% phosphate buffered formalin for 15 min, 100 mM NH4Cl and 0.5%
Igepal in PBS (pH 7.8) for 5 min each. Sections were denatured in 3 M
Guanidiniumthiocyanate/10 mM Tris–HCl (pH 7.8). They were blocked
overnightwith fetal calf serum inTBST/0.2% Tween 20 at 4 °C, incubated
with antibody 3F4 (1:100) for 1 h 45 min and then with biotinylated
secondary antibody Goat-anti-Mouse (Dako E 0433) (1:200) in PBS/1%
BSA. Finally the sections were incubated with Vectastain ABC Kit and
stained with preincubation and incubation solution containing 3,3-
Diaminobenzidin (DAB) to visualize the reaction product for 10min and
3 min, respectively. For negative controls, ganglia slices were incubated
in normal mouse serum (Dako) (1:1000) instead of mAb 3F4 prior to
incubationwith the secondary antibody. After FTIRMdata collection, the
ganglia on CaF2 windows were also immunostained accordingly.
2.3. FTIRM data collection
The FTIRM experiments were conducted at beamline U10B at the
National Synchrotron Light Source, Brookhaven National Laboratory
(Upton, NY). AThermoNicoletMagna 860 FTIR spectrometer, coupled to
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with synchrotron light as the infrared source. The microscope was
equipped with matching 32×Schwarzschild objectives, a motorized x–y
mapping stage, an adjustable rectangular aperture, and a mercury
cadmium telluride (MCT-A) detector. The aperture of the microscope
was set to 10×10 μm. A pre-deﬁned area of approximately 100×100 μm
encompassing about 15–20 cells was raster-scanned with a step size of
4 μm using Omnic software (ThermoNicolet). At each point, an
absorbance spectrum was recorded in transmission mode. Each
spectrum was collected in the mid-infrared spectral range (800–
4000 cm−1) with a spectral resolution of 8 cm−1 and 128 scans co-
added. Happ–Genzel apodization and a zero-ﬁlling of level 2 were
applied, resulting in approximately 1 data point per wave number. A
background spectrumon clean substratewas also recordedbyco-adding
512 scans. For each animal, one or two infrared maps were collected,
yielding an average of 10,500 spectra from 138 cells (∼29 cells per
animal) per time point from the infected animals and 8887 spectra from
110 cells (∼37 cells per animal) per time point from the controls.
2.4. Data analysis
The FTIRM data were analyzed using Thermo Nicolet's software
Omnic 7.3. Absorbances from 1616 to 1636 cm−1 of protein infrared
spectra are attributed primarily to β-sheet structures, which have
been shown to increase in studies of recombinant and protease-
resistant Syrian hamster PrP in vitro [13−16]. Thus, to examine the
relative content of β-sheet structure in the tissue, each absorbance
spectrum was integrated from 1624–1628 cm−1, applying a linear
baseline from 1480–1715 cm−1. To normalize for potential differences
in tissue thickness among samples, the β-sheet area was divided by
the area under the Amide I protein band (1600–1700 cm−1), applying
the same linear baseline. Accordingly, the relative α-helical content
was calculated by integrating each absorbance spectrum from 1654–
1658 cm−1 and normalizing to the area under the Amide I band. For
both α-helix and β-sheet content, narrow regions were integrated inFig. 2. (A) Photomicrographs of unstained cryosections (1st and 3rd column) and correspond
infected (right) ganglia at different time points. Scale bar: 20 μm.order to prevent overlap with other secondary structure elements
[17]. Chemical images in α-helix and β-sheet content were generated
using Transform (Fortner Software, USA). To estimate the relative
protein content at each pixel, the integrated area under the Amide I
protein band was divided by the area under the entire infrared
spectrum, in order to normalize for potential differences in tissue
thickness among samples. The total integrated area was calculated as
the integrated area from 2500–3700 cm−1 (baseline from 2500 to
3700 cm−1) plus the integrated area from 1760–1000 cm−1 (baseline
from 1760–1000 cm−1). The whole spectral regionwas chosen since it
includes the vibrational modes of C–H, N–H and O–H bonds of all
major biomolecules and therefore represents the total biomass. Thus,
by dividing the total protein by the total biomass, a relative estimate of
total protein content was determined.
For each animal, theα-helix,β-sheet, and total protein content were
determined for every pixel in each map. These values were averaged to
obtain a mean and standard deviation for each animal. Then the
individual animal values were averaged at their respective time points.
An unpaired, two-sided t-test (Student's t-test) was performed on all
data to test for signiﬁcant differences (pb0.05) between scrapie and
control at each time point, and differences between time points. In the
analysis, those spectra derived from areas outside the ganglion or from
tissue artifacts were excluded from the calculation.
3. Results
To examine changes in the secondary structure of proteins as a
function of disease severity, the mean values±standard deviation for
β-sheet content were calculated and plotted in Fig. 1A. As disease
progressed, results showed that the amount of β-sheet remained
relatively constant in control hamsters (gray line), but substantially
increased with time in the scrapie-infected animals (black line). The
most dramatic difference between the control and infected animals
was observed at 100 dpi, where the β-sheet content in scrapie-
infected ganglia was signiﬁcantly lower than in the control gangliaing FTIRM images (2nd and 4th column) of the β-sheet distribution for control (left) and
Fig. 3. Original and second derivative spectra derived from near the cell membrane (black line) and within the cytoplasm (gray line) of a 100 dpi scrapie-infected animal.
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increase in β-sheet content in the infected animals of about 8%
(p=0.003). In contrast, the β-sheet content in the control ganglia
remained unchanged over the time course studied here.
In contrast to the dramatic changes in β-sheet, Fig. 1B shows that
the α-helical content was unaffected by the disease (black line) or by
age (control, gray line).
To determine how the changes in protein structure were related to
total protein expression, the total protein content was determined as a
function of disease severity (Fig. 1C). At 100 dpi, the scrapie-infectedFig. 4. Photomicrographs of antibody 3F4-stained adjacent sections. PrPSc can be detected a
neuronal and satellite cells at later stages of incubation. Scale bar: 30 μm.animals (black line) showed a signiﬁcant increase in relative protein
content when compared to the control animals (p=0.020). Moreover,
the total protein content of scrapie-infected animals (black line)
declined gradually during pathogenesis and reached a signiﬁcantly
lower level at the terminal stage of the disease (p=0.013). The control
animals did not exhibit a change in total protein expression
throughout the time course studied here.
In addition to measuring relative protein content and structure,
the spatial distribution of β-sheet protein within the tissue was
also examined. In Fig. 2, photomicrographs and correspondings granular deposits of immunoreactive material (arrows) in many – but not all –of the
Fig. 5. Comparison of the results from the FTIRM of an infected animal at 100 dpi (left)
and ﬁrst clinical signs (right) with 3F4-stained sections of the same tissue.
Photomicrographs of the areas investigated with FTIRM are shown in the 1st row
(unstained) and 2nd row (3F4-antibody stained). The β-sheet and α-helix distributions
are represented in the 3rd and 4th rows, respectively. At 100 dpi, some areas show high
β-sheet as well as high α-helix (⁎), which was not observed at the terminal stage. Areas
with PrPSc deposition as seen in the 3F4 stained sections showed elevated β-sheet
(arrows), while some areas showed high β-sheet but no PrPSc deposition (arrowheads).
Scale bar: 20 μm.
563A. Kretlow et al. / Biochimica et Biophysica Acta 1782 (2008) 559–565FTIRM images of the intermolecular β-sheet distribution for
representative control (left) and infected (right) ganglia at different
time points are shown. In all images, the β-sheet content was
slightly higher near the cell's periphery and extracellular matrix.
For the control animals, the FTIRM images appeared similar at each
time point, indicating that the β-sheet distribution remained
constant over time. For the scrapie-infected animals, it can be
seen that the β-sheet content increased with the progression of the
disease, as indicated by more green, yellow, and red areas. At pre-
clinical time points, elevated β-sheet was detected in only a few
cells and exclusively near the cell membrane. Otherwise, these cells
generally exhibited proteins lower in β-sheet content than the
controls, as can be seen by the dark blue areas. During disease
progression, the number of affected cells increased such that, by
the terminal stage, overall content of β-sheet increased and was
observed throughout a large number of cells, including – but not
limited to – the cell's periphery.
To further investigate the distribution of α-helix, β-sheet, and
unordered structures in scrapie-infected tissue, second derivative
spectra from a 100 dpi scrapie-infected animal are plotted in Fig. 3.
These spectra were obtained from the regions marked with asterisks
in Fig. 2 (scrapie, 100 dpi panel). In most cells at 100 dpi, the typical
FTIR spectrum is primarily α-helical, with an intense absorption
feature at 1656 cm−1 (obtained from points in the center of the cell
indicated by white asterisk in Fig. 2.) However, the area near the cell
membrane (black asterisk in Fig. 2) exhibited spectra with increased
peak intensities at 1681 cm−1 (attributed to β-turns and loops), 1638
and 1632 cm−1 (attributed to β-sheet), and a broad shoulder at around
1648 cm−1 (attributed to unordered structures), while the intensity of
the α-helical peak at around 1656 cm−1 was shown to decrease
slightly [16], indicating changes in a number of secondary structures
beyond α-helix and β-sheet.
Since the FTIRM data showed an increase in β-sheet content
with disease progression, consistent with the accumulation of PrPSc,
immunostaining with the 3F4 antibody for the prion protein was
performed on adjacent tissue sections (Fig. 4). Due to the fact that
the antibody 3F4 stains both the cellular and the misfolded form of
the prion protein [18], a more or less homogeneous brown
background can be seen in all images, where the intensity or
distribution does not signiﬁcantly change between time points or
infection state. However, in the infected tissue, comparative
immunohistochemical and PET blot staining has shown that PrPSc
accumulates as microdisperse aggregates that present as character-
istic granular deposits of immunoreactive material [5]. Fig. 4 shows
a clear progression of PrPSc deposition during pathogenesis by the
increased appearance of brown, granular, immunoreactive material,
indicating the presence of pathologically aggregated PrP. At 100 dpi,
very few neurons and satellite cells showed such immunostaining
for PrPSc, whereas the accumulation of PrPSc became more
prominent at later stages of incubation as indicated by the
increasing number of characteristic granular deposits at 130 dpi,
fcs, and at the terminal stage of disease.
To directly correlate the elevated β-sheet content with the
distribution of aggregated PrPSc, the FTIRM samples were subse-
quently stained with the 3F4 monoclonal antibody. Fig. 5 shows
the results for an infected animal at 100 dpi (left column) and at
ﬁrst clinical signs (right column). The ﬁrst row displays the un-
stained photomicrographs, while the second row shows the same
tissue stained with the 3F4 antibody. At 100 dpi, the immunos-
tained section showed no evidence of PrPSc inside the neurons, but
in some of the surrounding satellite cells (arrows). The third and
fourth rows represent the β-sheet and α-helix distributions,
respectively, as measured with FTIRM. At 100 dpi, the satellite
cells that stained positive for PrPSc also had higher β-sheet content.
Furthermore, some areas showed both elevated β-sheet and α-
helical content (asterisks). At fcs, some neurons stained positive forPrPSc (as can be seen by granular deposits and indicated by arrows)
and showed a high content of β-sheet in the corresponding FTIRM
map (e.g. the cell in the center of the image). In contrast, the cell
shown in the upper left of the fcs photomicrograph (arrowhead)
shows elevated β-sheet content but no PrPSc staining, indicating
that β-sheet rich proteins other than PrPSc also increased during
pathogenesis.
4. Discussion
FTIR spectra of isolated PrP fragments (PrP27–30) and protease-
resistant PrP (PrPres) from 263K scrapie-infected hamster were
shown to exhibit strong absorbance bands at around 1636 and
1626 cm−1, indicating the presence of β-sheet structures [13,14,16]
Furthermore, under destabilizing conditions and low pH, recombi-
nant Syrian hamster prion protein showed dominant amide I band
components at 1620 and 1691 cm−1, which are generally assigned to
intermolecularly arranged antiparallel β-sheet structures [15]. Site-
directed spin labeling, EPR spectroscopy, and time resolved FTIR
studies revealed that the conformational conversion of PrPC into
PrPSc involves major refolding of the C-terminal α-helical region of
PrPC [19,20]. But not all α-helices get converted into β-sheet, as was
shown by NMR [21]. However, while FTIR spectroscopy has been
able to identify structural changes in PrP in vitro and ex situ,
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has been difﬁcult.
Recently, a FTIRM study of terminally-diseased, 263K scrapie
hamsters was the ﬁrst to show a higher β-sheet content and a lower
α-helical content in infected DRG cells [22,23]. Here, this study was
extended to pre-clinical time points, and we ﬁnd signiﬁcant changes
in protein structure, composition, and distribution throughout the
course of the disease, while age-matched control animals did not
exhibit any changes over the investigated time period. Speciﬁcally, we
ﬁnd that elevated β-sheet content was detectable earlier in the
disease, i.e. with the onset of the ﬁrst clinical signs. These ﬁndings are
consistent with work by McBride, et al., who used immunostaining to
show PrPSc accumulation as early as 76 days post-infection in the 263K
scrapie hamster model [5].
Over the course of the disease, results showed that the increase
in β-sheet was ∼8%, well above the amount attributable to PrPSc,
which was shown to represent only 0.1% of all proteins in the tissue
at terminal stage [24]. Furthermore, FTIRM and corresponding
immunostain images revealed that not all areas with elevated β-
sheet stained positive for PrPSc, indicating that other β-sheet rich
proteins also play a role in scrapie pathogenesis. Gene proﬁling of
263K scrapie-infected hamster identiﬁed several upregulated genes
at the terminal time point [25,26]. Among those were proteins with
predominantly β-sheet content, such as metallothionein [27],
apolipoprotein J [28], IP-10 [29,30] and β2-microglobulin, the last
of which was shown to have amyloidogenic properties [31].
However, since FTIRM spectra represent the average protein
structure within the volume of tissue illuminated by the infrared
light, speciﬁc identiﬁcation of these proteins is beyond the scope of
this study.
While an increase in β-sheet content towards the terminal stage of
the disease conﬁrmed our initially proposed hypothesis, a signiﬁ-
cantly lower amount of β-sheet protein at pre-clinical time points was
an unexpected ﬁnding. Since the total protein content was signiﬁ-
cantly increased in the scrapie-infected animals at 100 dpi, we suggest
that the early scrapie infection is characterized by an overexpression
of proteins low in β-sheet content. Second derivative analysis
conﬁrmed that most spectra showed predominantly high α-helical
content; however some spectra recorded near the cell's periphery
exhibited an increase in random coil and β-sheet content. Immuno-
histochemistry studies have previously shown that the deposition of
pathological PrPSc starts in satellite cells and in the cytoplasm and
plasmalemma of neurons [6]. PrPSc accumulation near the cell
membrane has also been observed in scrapie-infected mouse
neuroblastoma cells [32], in cultured Chinese hamster ovary cells
[33], in the medulla oblongata, pons, and astrocytes of sheep [34], and
mice with natural scrapie [35,36].
At later stages of pathogenesis, the β-sheet content increased
throughout the cell, which is consistent with (but not exclusively
attributed to) the appearance of PrPSc aggregates in the cytoplasm of
neurons, primarily in secondary lysosomes [37], aggresomes [38], and
in the nucleus [39]. Interestingly, accumulation of PrP in the cytosol
has been shown to be neurotoxic [40,41].
In summary, this study showed that pronounced protein-related
changes occur at the very early stages of scrapie pathogenesis, well
before clinical symptoms appear. Moreover, these changes go well
beyond the transformation of PrPC to PrPSc. In the future, efforts to
identify these speciﬁc proteins that are involved at pre-clinical time
points may provide an avenue for early disease detection and
possible targets for treatment of scrapie infection that are not
available today.
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